HIGH-DOSE 5-FLUOROURACIL (5-FU) AND FOLINIC ACID IN ADVANCED COLORECTAL SITES OF DISEASE CANCER RESISTANT TO STANDARD-DOSE LOCAL 5-FU TREATMENT - RESULTS OF A LIVER PHASE-II STUDY

被引：14
|
作者：
JAGER, E [1 ]
KLEIN, O [1 ]
WACHTER, B [1 ]
MULLER, B [1 ]
BRAUN, U [1 ]
KNUTH, A [1 ]
机构：
[1] KRANKENHAUS NW FRANKFURT,MED KLIN 2,D-60488 FRANKFURT,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷 / 10期
关键词：
D O I：
10.1016/0959-8049(95)00238-E
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1717 / 1717
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF ADVANCED COLORECTAL (CRC) AND GASTRIC ADENOCARCINOMAS (GC) WITH 5-FU AND HIGH-DOSE FOLINIC ACID (FA)
    MACHOVER, D
    GOLDSCHMIDT, E
    CHOLLET, P
    METZGER, G
    SCHWARZENBERG, L
    MISSET, JL
    TIMUS, M
    VANDENBULCKE, JM
    ZITTOUN, J
    MATHE, G
    ANTICANCER RESEARCH, 1985, 5 (06) : 576 - 576
  • [22] Treatment of colorectal cancer with a simultaneous application of 5-fluorouracil (5-FU)/sodium folinic acid: Results of a large observation study
    Hofheinz, R. D.
    Hutschenreuther, U.
    Sauer, U.
    Eschenburg, H.
    Rudolph, R.
    Tummes, D.
    Weinberg, R.
    Guggenberger, D.
    ANNALS OF ONCOLOGY, 2008, 19 : I44 - I44
  • [23] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [24] 5-FLUOROURACIL (5-FU), METHYL-CCNU, AND VINCRISTINE IN TREATMENT OF ADVANCED COLORECTAL CANCER - PHASE-2 STUDY UTILIZING WEEKLY 5-FU
    MACDONALD, JS
    KISNER, DF
    SMYTHE, T
    WOOLLEY, PV
    SMITH, L
    SCHEIN, PS
    CANCER TREATMENT REPORTS, 1976, 60 (11): : 1597 - 1600
  • [25] Phase II study of weekly high-dose infusional (HD-CI) 5-fluorouracil (5-FU) in advanced pancreatic carcinoma
    Lutz, MP
    Koniger, M
    Muche, R
    Adler, G
    Gress, TM
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 54
  • [26] Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
    Gamelin, EC
    DanquechinDorval, EM
    Dumesnil, YF
    Maillart, PJ
    Goudier, MJ
    Burtin, PC
    Delva, RG
    Lortholary, AH
    Gesta, PH
    Larra, FG
    CANCER, 1996, 77 (03) : 441 - 451
  • [27] REVERSAL OF 5-FLUOROURACIL (5-FU) INDUCED MYELOSUPPRESSION BY HIGH-DOSE URIDINE (UR)
    VANGROENINGEN, CJ
    LEYVA, A
    PETERS, GJ
    LAURENSSE, E
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 169 - 169
  • [28] 2ND-LINE TREATMENT WITH HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER REFRACTORY TO STANDARD-DOSE 5-FLUOROURACIL TREATMENT
    JAGER, E
    KLEIN, O
    WACHTER, B
    MULLER, B
    BRAUN, U
    KNUTH, A
    ONCOLOGY, 1995, 52 (06) : 470 - 473
  • [29] DTIC + MMC IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER AFTER FAILURE WITH HIGH-DOSE FOLINIC ACID PLUS 5-FU
    BARONE, C
    GARUFI, C
    ASTONE, A
    GRIECO, A
    BARONI, R
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1987, 6 (01) : 63 - 65
  • [30] FOLINIC ACID + 5-FLUOROURACIL (5-FU) VERSUS EQUIDOSE 5-FU IN ADVANCED COLORECTAL-CANCER - PHASE-III STUDY OF GISCAD (ITALIAN-GROUP-FOR-THE-STUDY-OF-DIGESTIVE-TRACT-CANCER)
    LABIANCA, R
    PANCERA, G
    AITINI, E
    BARNI, S
    BERETTA, A
    BERETTA, GD
    CESANA, B
    COMELLA, G
    COZZAGLIO, L
    CRISTONI, M
    SPAGNOLLI, P
    FRONTINI, L
    GOTTARDI, O
    MARTIGNONI, G
    SCAPATICCI, R
    SMERIERI, F
    VINCI, M
    ZADRO, A
    ZANIBONI, A
    LUPORINI, G
    ANNALS OF ONCOLOGY, 1991, 2 (09) : 673 - 679
12345